137 related articles for article (PubMed ID: 36366811)
21. Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival.
Odei B; Boothe D; Suneja G; Werner TL; Gaffney DK
Am J Clin Oncol; 2018 Aug; 41(8):784-791. PubMed ID: 28121642
[TBL] [Abstract][Full Text] [Related]
22. Uterine carcinosarcoma.
Arend R; Doneza JA; Wright JD
Curr Opin Oncol; 2011 Sep; 23(5):531-6. PubMed ID: 21743326
[TBL] [Abstract][Full Text] [Related]
23. OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma.
An Y; Wang Q; Sun F; Zhang G; Wang F; Zhang L; Li Y; Ren W; Zhu W; Li Y; Ji S; Guo X
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899312
[TBL] [Abstract][Full Text] [Related]
24. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
25. Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma.
McEachron J; Heyman T; Shanahan L; Tran V; Friedman M; Gorelick C; Economos K; Singhal PK; Lee YC; Kanis MJ
Int J Gynecol Cancer; 2020 Jul; 30(7):1012-1017. PubMed ID: 32447295
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database.
Tang LS; Zhou YW; Wang JL; Zhang GX; Xu CH; Liu JY; Qiu M
BMJ Open; 2023 Dec; 13(12):e077974. PubMed ID: 38101828
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant Treatment Modalities, Prognostic Factors, and Outcome of the Uterine Carcinosarcoma.
Kahramanoglu I; Demirkiran F; Turan H; Bese T; Cebi S; Ilvan S; Arvas M
J Obstet Gynaecol Can; 2021 Jan; 43(1):34-42. PubMed ID: 33041218
[TBL] [Abstract][Full Text] [Related]
28. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
Brooks SE; Zhan M; Cote T; Baquet CR
Gynecol Oncol; 2004 Apr; 93(1):204-8. PubMed ID: 15047237
[TBL] [Abstract][Full Text] [Related]
29. Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.
Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
Gynecol Oncol; 2016 Jun; 141(3):447-453. PubMed ID: 27072806
[TBL] [Abstract][Full Text] [Related]
30. Cancer incidence and survival among adolescents and young adults in Korea.
Moon EK; Park HJ; Oh CM; Jung KW; Shin HY; Park BK; Won YJ
PLoS One; 2014; 9(5):e96088. PubMed ID: 24789075
[TBL] [Abstract][Full Text] [Related]
31. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
Garg G; Kruger M; Christensen C; Deppe G; Toy EP
Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
[TBL] [Abstract][Full Text] [Related]
32. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
Matsuo K; Takazawa Y; Ross MS; Elishaev E; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Yanai S; Takeuchi S; Nishimura M; Iwasaki K; Johnson MS; Yoshida M; Hakam A; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Kajiwara H; Hasegawa K; Yasuda M; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Pejovic T; Nagano T; Sasaki T; Richmond AM; Post MD; Shahzad MMK; Im DD; Yoshida H; Enomoto T; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
Ann Surg Oncol; 2018 Sep; 25(9):2756-2766. PubMed ID: 29971677
[TBL] [Abstract][Full Text] [Related]
33. Trends of Incidence and Survival Rates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database.
Jeong SH; Hyun SY; Choi JS; Kim HM
J Korean Med Sci; 2020 Sep; 35(36):e294. PubMed ID: 32924338
[TBL] [Abstract][Full Text] [Related]
34. Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?
Güngördük K; Plett H; Gülseren V; Meydanlı M; Boyraz G; Özdemir İ; Şahin H; Şenol T; Yıldırım N; Turan T; Öge T; Gökçü M; Taşkın S; Ayhan A; Ataseven B
Oncol Res Treat; 2021; 44(1-2):43-51. PubMed ID: 33249415
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.
Van Arsdale AR; Arend RC; Cossio MJ; Erickson BK; Wang Y; Doo DW; Leath CA; Goldberg GL; Huang GS
Cancer Med; 2018 Mar; 7(3):616-625. PubMed ID: 29455465
[TBL] [Abstract][Full Text] [Related]
36. Incidence and survival rates of lymphoepithelioma-like gastric carcinoma: analysis of the Korea Central Cancer Registry Database.
Kim JW; Kim JH; Kim HM
Scand J Gastroenterol; 2021 Oct; 56(10):1182-1186. PubMed ID: 34338128
[TBL] [Abstract][Full Text] [Related]
37. Is there an increase in the incidence of uterine carcinosarcoma in north-east Scotland? A 19 years population-based cohort study.
Gurumurthy M; Lahiri R; Scott N; Miller I; Cruickshank ME; Parkin DE
Scott Med J; 2013 May; 58(2):88-94. PubMed ID: 23728753
[TBL] [Abstract][Full Text] [Related]
38. Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?
Sinha R; Nizam A; Shan W; Shih KK; Frimer M; Sakaris A; Goldberg GL
J Robot Surg; 2022 Aug; 16(4):943-949. PubMed ID: 34716874
[TBL] [Abstract][Full Text] [Related]
39. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.
Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
Surg Oncol; 2019 Jun; 29():25-32. PubMed ID: 31196490
[TBL] [Abstract][Full Text] [Related]
40. Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival.
Raffone A; Travaglino A; Raimondo D; Maletta M; De Vivo V; Visiello U; Casadio P; Seracchioli R; Zullo F; Insabato L; Mollo A
Int J Gynaecol Obstet; 2022 Sep; 158(3):520-527. PubMed ID: 34797919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
